Results 21 to 30 of about 8,048 (187)

Trichloroethylene increases pulmonary endothelial permeability: implication for pulmonary veno-occlusive disease [PDF]

open access: yesPulmonary Circulation, 2020
Trichloroethylene exposure is a major risk factor for pulmonary veno-occlusive disease. We demonstrated that trichloroethylene alters the endothelial barrier integrity, at least in part, through vascular endothelial (VE)-Cadherin internalisation, and ...
Julien Caliez   +14 more
doaj   +2 more sources

Pulmonary veno-occlusive disease in Sjogren's syndrome: a case report [PDF]

open access: yesBMC Pulmonary Medicine, 2023
Background Pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD) belongs to Group 1 pulmonary hypertension. Pulmonary veno-occlusive disease (PVOD), which is characterized by venous system aberrations, has been previously ...
Xiaofang Zeng   +8 more
doaj   +2 more sources

Pulmonary veno-occlusive disease: illustrative cases and literature review [PDF]

open access: yesEuropean Respiratory Review
Pulmonary veno-occlusive disease (PVOD), also known as “pulmonary arterial hypertension (PAH) with overt features of venous/capillary involvement”, is a rare cause of PAH characterised by substantial small pulmonary vein and capillary involvement ...
Benoit Lechartier   +7 more
doaj   +2 more sources

Pulmonary arterial hypertension associated with pulmonary arteriovenous malformations and pulmonary veno-occlusive disease: A devastating combination [PDF]

open access: yesRespiratory Medicine Case Reports, 2021
We describe a case of an adolescent male with the rare combination of pulmonary arterial hypertension (PAH) and pulmonary arteriovenous malformations (PAVM's) without confirmed hereditary hemorrhagic telangiectasia (HHT).
Baukje M. Zaaijer   +7 more
doaj   +2 more sources

Novel AGL variants in a patient with glycogen storage disease type IIIb and pulmonary hypertension caused by pulmonary veno-occlusive disease: A case report [PDF]

open access: yesFrontiers in Genetics, 2023
Glycogen storage disease type III (GSD-III) is an autosomal recessive metabolic disorder caused by mutations in the AGL gene, and may develop various types of pulmonary hypertension (PH).
Akito Shindo   +10 more
doaj   +2 more sources

Anti-synthetase syndrome-associated pulmonary veno-occlusive disease [PDF]

open access: yesPulmonary Circulation, 2020
Pulmonary arterial hypertension has been reported with a prevalence of 7.9% in patients with anti-synthetase syndrome; however, anti-synthetase syndrome associated with pulmonary veno-occlusive disease (PVOD) has never before been described in the ...
Dana Kay   +5 more
doaj   +2 more sources

Outcomes and risk assessment in pulmonary veno-occlusive disease [PDF]

open access: yesERJ Open Research
Introduction Pulmonary veno-occlusive disease (PVOD) is a rare and severe subtype of pulmonary arterial hypertension (PAH). Although European Society of Cardiology/European Respiratory Society (ESC/ERS) guidelines advise assessing PAH severity at ...
Athénaïs Boucly   +17 more
doaj   +2 more sources

Late Onset Pulmonary Arterial Hypertension Associated With Features of Pulmonary Veno‐Occlusive Disease and Rare Heterozygous Variants of KDR and EIF2AK4 [PDF]

open access: yesPulmonary Circulation
The natural history of late‐onset pulmonary arterial hypertension (PAH) with features of venous/capillary involvement and the associations with rare variants in PAH genes are not well known.
Vasile Foris   +11 more
doaj   +2 more sources

Mechanisms underlying age-associated exacerbation of pulmonary veno-occlusive disease [PDF]

open access: yesJCI Insight
Pulmonary veno-occlusive disease (PVOD) is a rare but severe form of pulmonary hypertension characterized by the obstruction of pulmonary arteries and veins, causing increased pulmonary artery pressure and leading to right ventricular (RV) heart failure.
Amit Prabhakar   +8 more
doaj   +2 more sources

Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension. [PDF]

open access: yes, 2016
BACKGROUND: Pulmonary arterial hypertension (PAH) is a rare disease with an emerging genetic basis. Heterozygous mutations in the gene encoding the bone morphogenetic protein receptor type 2 (BMPR2) are the commonest genetic cause of PAH, whereas ...
Charaka Hadinnapola   +325 more
core   +26 more sources

Home - About - Disclaimer - Privacy